By Chris Wack Harmony Biosciences Holdings shares rebounded 9% to $23.04 from Friday’s drop, when the company said its Phase 3 study missed the primary…
Markets – MarketWatch
Harmony Biosciences Shares Rebound From Friday’s 52-Week Low Markets – MarketWatch
